Post-earnings recap
Reported
Mon, Jul 29, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report indicates a slight miss on EPS expectations, which contributed to a significant drop in stock price by 7.73%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of the challenges ahead and are prioritizing long-term strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | -2.75% |
Management expressed concern over recent performance, highlighting the need for strategic adjustments. They remain focused on future growth despite current challenges.
Management acknowledged challenges in meeting expectations.
They emphasized a focus on long-term strategies despite short-term setbacks.